[HTML][HTML] Drug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy
A Citri, I Alroy, S Lavi, C Rubin, W Xu… - The EMBO …, 2002 - embopress.org
A Citri, I Alroy, S Lavi, C Rubin, W Xu, N Grammatikakis, C Patterson, L Neckers, DW Fry…
The EMBO journal, 2002•embopress.orgDrug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications
for cancer therapy | The EMBO Journal All EMBO Press journals Open Access as of 1 January
2024 - read the FAQs logo embp press logo JOURNALS The EMBO Journal The EMBO
Journal The EMBO Journal EMBO Reports The Reports EMBO Reports Molecular Systems
Biology Molecular Systems Biology Molecular Systems Biology EMBO Molecular Medicine
EMBO Molecular Medicine EMBO Molecular Medicine Life Science Alliance Life Science …
for cancer therapy | The EMBO Journal All EMBO Press journals Open Access as of 1 January
2024 - read the FAQs logo embp press logo JOURNALS The EMBO Journal The EMBO
Journal The EMBO Journal EMBO Reports The Reports EMBO Reports Molecular Systems
Biology Molecular Systems Biology Molecular Systems Biology EMBO Molecular Medicine
EMBO Molecular Medicine EMBO Molecular Medicine Life Science Alliance Life Science …
Results
A kinase‐defective mutant of ErbB‐1 is a preferred substrate for the GA‐induced mechanism of receptor ubiquitylation
embopress.org